Arcoma ABOSTO:ARCOMA -1.87%75 OCF Yield % is 16.31 as of Jul. 03, 2026, which is 641% above its 10-year median of 2.20. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.86 (Fairly Valued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Arcoma AB ranks better than 93.79% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Arcoma AB's OCF Yield % or its related term are showing as below:
OSTO:ARCOMA'
s OCF Yield % Range Over the Past 10 Years
Min: -31.06 Med: 2.2 Max: 20.73
Current: 16.31
During the past 13 years, the highest OCF Yield % of Arcoma AB was 20.73%. The lowest was -31.06%. And the median was 2.20%.
OSTO:ARCOMA's OCF Yield % is ranked better than 93.79% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs OSTO:ARCOMA: 16.31
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Arcoma AB OCF Yield % Related Terms
Arcoma AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for Arcoma AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ARCOMA vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Arcoma AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcoma AB OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Arcoma AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcoma AB (OSTO:ARCOMA) has a OCF Yield % of 16.31 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Arcoma AB and its competitors. This is 641% above median its historical median of 2.20. According to the industry distribution chart, Arcoma AB ranks #53 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 6.2%.
Is Arcoma AB's OCF Yield % too high?
Arcoma AB's current OCF Yield % of 16.31 is 641% above median its 10-year median of 2.20. The Medical Devices & Instruments industry median OCF Yield % is 1.68. Arcoma AB's value of 16.31 is 870.8% above this industry median. Based on the distribution chart, Arcoma AB ranks #53 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #53 out of 854 companies for OCF Yield %. This places Arcoma AB in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.68. Arcoma AB's value of 16.31 is 870.8% above this benchmark. While the company's 10-year median is 2.20 vs. the industry median of 1.68, Arcoma AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.68, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcoma AB's current OCF Yield % of 16.31 is 870.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Arcoma AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcoma AB's current OCF Yield % is 16.31, which is 641% above median its own 10-year median of 2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.86, compared to a current price of kr8.40 — trading 6.9% above its estimated fair value. The current OCF Yield % is 16.31, which is 641% above median its 10-year median of 2.20 and 870.8% above the Medical Devices & Instruments industry median of 1.68. Arcoma AB's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current OCF Yield % is 16.31 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued.
The current stock price of kr8.40 is trading 6.9% above its estimated GF Value™ of kr7.86.
GuruFocus considers Arcoma AB to be Fairly Valued.
Key valuation signals for OSTO:ARCOMA:
OCF Yield %: 16.31 (641% above median its 10-year median of 2.20)
GF Value™: kr7.86 vs. price of kr8.40 (6.9% above fair value)
Industry Position: 870.8% above the Medical Devices & Instruments median (#53 of 854)
No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score
Get the complete analysis for OSTO:ARCOMA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ARCOMA has been successfully added to your 
